Hutch News
Results per Page:
Cancer clinical trials exclude too many patients: That’s changing
Calls for equity, inclusion and better access boost pre-pandemic efforts to open up eligibility, streamline trials
Tip Sheet: COVID-19 vaccines, SARS-CoV-2 mutations, shedding pandemic pounds – and nematode nerve cells
Summaries of recent Fred Hutch research findings and other news
Shed the pandemic pounds ... and the stupor
As vaccines roll out and the crisis ebbs, get more sleep, eat mostly plants, keep moving and stay connected
Cancer patients and the COVID-19 vaccines
Clinicians, cancer patients and coronavirus researchers weigh in on vaccination safety, timing, allergy concerns and more
What’s new in breast cancer research? SABCS20 goes virtual
Hutch scientists share findings on treatment, imaging, CAR T therapy, COVID-19’s impact on cancer patients and more
New cancer drugs lead to life-threatening financial choices
Hutch researchers in HICOR take on one of cancer treatment’s deadliest side effects, financial toxicity; call for Medicare policy change
Fred Hutch at ASH: Fauci fireside chat, latest on cell therapies, repairing immune function, COVID and clots — and more
The 62nd American Society of Hematology Annual Meeting and Exposition to be held virtually Dec. 5-8, 2020
The latest on how COVID-19 affects cancer patients
Hutch researchers share new data on mortality rates and racial disparities in treatment; launch statewide COVID-19 and cancer data repository
What happens when cancer patients get COVID-19?
Large new observational study of nearly 1,000 patients breaks down who’s most at risk with coronavirus, highlights need for additional care
Treating cancer in the shadow of coronavirus
Patients, doctors and researchers triage, tweak, pivot and try not to panic during the COVID-19 pandemic
COVID-19: What our scientists are saying
Fred Hutch researchers provide their insights and ideas on the pandemic
COVID-19: 'Social distancing' in Seattle and beyond
Stopping a pandemic in its tracks calls for cooperation, patience, handwashing and, yes, isolation. We can do it.
What’s the best way to screen dense breasts?
‘Abbreviated’ MRI beats 3D mammography in new screening study, but cost and utilization remain big questions
Fred Hutch at ASCO: HPV vaccine uptake in U.S., immunotherapy and sarcoma, financial toxicity of cancer, health care disparities and more
The American Society of Clinical Oncology will hold its annual meeting May 31-June 4 in Chicago
Aiming to reduce the risk for venous thromboembolism
From the Lyman Group, Divisions of Public Health Sciences and Clinical Research
Blood clots: What cancer patients need to know
A common side effect of cancer and its treatment gets renewed attention and potential new therapies
Dr. Veena Shankaran joins leadership of Fred Hutch’s health care economics and policy research institute
She will contribute to strategic planning, scientific priority setting, fundraising and organizational development
ASCO endorses integrative oncology guidelines for breast cancer patients
Yoga, meditation, acupuncture and more can be safely used to relieve side effects of standard treatment
Fred Hutch at ASCO
Immunotherapy advances, insights into health economics and leadership awards dominate oncology gathering
At half the cost, Canadian colorectal cancer survival similar to that of U.S.
Cross-border collaboration compared findings in British Columbia and Washington state